Cargando…
Non-invasive tests for the prediction of primary hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world and it is one of the main complications of cirrhosis and portal hypertension. Even in the presence of a well-established follow-up protocol for cirrhotic patients, to date poor data are available on predictive markers...
Autores principales: | Marasco, Giovanni, Colecchia, Antonio, Silva, Giovanni, Rossini, Benedetta, Eusebi, Leonardo Henry, Ravaioli, Federico, Dajti, Elton, Alemanni, Luigina Vanessa, Colecchia, Luigi, Renzulli, Matteo, Golfieri, Rita, Festi, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327793/ https://www.ncbi.nlm.nih.gov/pubmed/32655261 http://dx.doi.org/10.3748/wjg.v26.i24.3326 |
Ejemplares similares
-
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments
por: Marasco, Giovanni, et al.
Publicado: (2020) -
Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis
por: Marasco, Giovanni, et al.
Publicado: (2022) -
Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness
por: Dajti, Elton, et al.
Publicado: (2021) -
Clinical Presentation of Celiac Disease and Diagnosis Accuracy in a Single-Center European Pediatric Cohort over 10 Years
por: Di Biase, Anna Rita, et al.
Publicado: (2021) -
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients
por: Ravaioli, Federico, et al.
Publicado: (2018)